Trials / Completed
CompletedNCT03071081
Study for Safety and Tolerability of TOP1288 Administered Orally in Healthy Subjects
A Phase 1 Study to Evaluate the Safety, Tolerability and Pharmacokinetics of TOP1288 Oral Single Ascending and Multiple Doses in Healthy Volunteers
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 37 (actual)
- Sponsor
- Topivert Pharma Ltd · Industry
- Sex
- Male
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
This study evaluates the safety and tolerability of TOP1288 oral single ascending and multiple doses in healthy subjects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | TOP1288 | Oral TOP1288 |
| DRUG | Placebo to TOP1288 | Oral placebo to TOP1288 |
Timeline
- Start date
- 2017-02-08
- Primary completion
- 2017-06-02
- Completion
- 2017-06-02
- First posted
- 2017-03-06
- Last updated
- 2018-09-20
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT03071081. Inclusion in this directory is not an endorsement.